Regado Biosciences' Series D - II Round

Regado Biosciences raised a round of funding on July 01, 2011.

Regado Biosciences, a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. The Company provides REG1 that is used in patients sufferin…

Articles about Regado Biosciences' Series D - II Round: